These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 18437085

  • 1. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.
    Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Balci MK, Omer A, Griffith TS, Sanlioglu S.
    Pancreas; 2008 May; 36(4):385-93. PubMed ID: 18437085
    [Abstract] [Full Text] [Related]

  • 2. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S, Koike N, Adachi S.
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [Abstract] [Full Text] [Related]

  • 3. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
    Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Ozdogan M, Suleymanlar I, Balci MK, Griffith TS, Sanlioglu S.
    Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
    [Abstract] [Full Text] [Related]

  • 4. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.
    Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ.
    Diabetologia; 2002 Dec; 45(12):1678-88. PubMed ID: 12488957
    [Abstract] [Full Text] [Related]

  • 5. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD, Korcum AF, Pestereli E, Erdogan G, Karaveli S, Savas B, Griffith TS, Sanlioglu S.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):716-23. PubMed ID: 17512128
    [Abstract] [Full Text] [Related]

  • 6. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, Grataroli R.
    J Cell Physiol; 2006 Mar 01; 206(3):709-17. PubMed ID: 16245307
    [Abstract] [Full Text] [Related]

  • 7. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
    Li Y, Wang H, Wang Z, Makhija S, Buchsbaum D, LoBuglio A, Kimberly R, Zhou T.
    Cancer Res; 2006 Sep 01; 66(17):8520-8. PubMed ID: 16951164
    [Abstract] [Full Text] [Related]

  • 8. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
    Cappellini A, Mantovani I, Tazzari PL, Grafone T, Martinelli G, Cocco L, Martelli AM.
    Int J Mol Med; 2005 Dec 01; 16(6):1041-8. PubMed ID: 16273284
    [Abstract] [Full Text] [Related]

  • 9. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1018-24. PubMed ID: 15808757
    [Abstract] [Full Text] [Related]

  • 10. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Hum Pathol; 2005 Oct 05; 36(10):1066-73. PubMed ID: 16226105
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E, Vodjgani M, Massoud A, Keyhani A, Rajab A, Shafaghi B, Gheflati Z, Aboufazeli T.
    Iran J Immunol; 2007 Dec 05; 4(4):197-205. PubMed ID: 18057577
    [Abstract] [Full Text] [Related]

  • 12. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
    Keogh RJ, Harris LK, Freeman A, Baker PN, Aplin JD, Whitley GS, Cartwright JE.
    Circ Res; 2007 Mar 30; 100(6):834-41. PubMed ID: 17322170
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.
    Rizzardi C, Leocata P, Ventura L, Zweyer M, Brollo A, Schneider M, Melato M.
    Anticancer Res; 2009 Apr 30; 29(4):1137-42. PubMed ID: 19414356
    [Abstract] [Full Text] [Related]

  • 14. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM.
    Gastroenterology; 2006 Jun 30; 130(7):1962-74. PubMed ID: 16762619
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.
    J Clin Oncol; 2006 Nov 01; 24(31):4998-5004. PubMed ID: 17075118
    [Abstract] [Full Text] [Related]

  • 16. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.
    Hu JK, Yang K, Li CM, Zhang B, Chen ZX, Chen XZ, Chen JP.
    Oncol Rep; 2009 Mar 01; 21(3):681-8. PubMed ID: 19212626
    [Abstract] [Full Text] [Related]

  • 17. DR5 and DcR2 are expressed in human lumbar intervertebral discs.
    Chen B, Ma B, Yang S, Xing X, Gu R, Hu Y.
    Spine (Phila Pa 1976); 2009 Sep 01; 34(19):E677-81. PubMed ID: 19730199
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Elders RC, Baines SJ, Catchpole B.
    Vet Immunol Immunopathol; 2009 Jul 15; 130(1-2):11-6. PubMed ID: 19185923
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M, Sykora J, Walczak H, Teh BT, Autschbach F, Herpel E, Schirmacher P, Roth W.
    Clin Cancer Res; 2009 Jan 15; 15(2):650-9. PubMed ID: 19147771
    [Abstract] [Full Text] [Related]

  • 20. Distinct function of monoclonal antibody to TRAIL-R2 as potentiator or inhibitor of the ligand TRAIL-induced apoptosis.
    Mori E, Thomas M, Motoki K, Kataika S.
    FEBS Lett; 2005 Oct 10; 579(24):5379-84. PubMed ID: 16199041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.